Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Nastech Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer
Jun 10, 2008 04:16 PM
- Nastech Announces Positive Intranasal Insulin Data at American Diabetes Association Meeting
Jun 09, 2008 08:02 AM
- Nastech Announces First Quarter 2008 Financial Results
May 08, 2008 04:01 PM
- Nastech to Release First Quarter Financial Results and Host Webcast on Thursday, May 8, 2008
May 01, 2008 04:04 PM
- Nastech Pharmaceutical Company Inc. Raises $7.93 Million in Registered Direct Offering
Apr 25, 2008 08:03 AM
- Nastech to Manufacture Nascobal(R) Nasal Spray for QOL Medical
Oct 17, 2005 02:27 PM
- First Pet Life Has Partnered With PetCo, Announces the OTC Report
Jun 24, 2005 01:31 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
NSTK
|
Compare to S&P
|
| YTD |
-69.47 %
|
-0.01 %
|
| 4 Weeks |
-10.77 %
|
-8.34 %
|
| 12 Weeks |
-51.26 %
|
-52.88 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -23.40 %
|
|
EPS Growth in Last Year: -23.40 %
|
|
Sales Growth in Last Quarter: -80.23 %
|
|
Sales Growth in Last Quarter: -74.70 %
|
|
|
